Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prometheus Biosciences Inc
(NQ:
RXDX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prometheus Biosciences Inc
< Previous
1
2
3
4
5
Next >
Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal
April 18, 2023
Shares of its takeover candidate nearly doubled on the news.
Via
Investor's Business Daily
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry
April 18, 2023
EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END
Via
FinancialNewsMedia
Expert Ratings for Prometheus Biosciences
April 17, 2023
Via
Benzinga
Crude Oil Down 2%; State Street Shares Tumble After Downbeat Results
April 17, 2023
U.S. stocks traded slightly lower toward the end of trading. The Dow traded down 0.07% to 33,862.05 while the NASDAQ fell 0.24% to 12,093.82. The S&P 500, also fell, dropping, 0.17% to 4,130.78.
Via
Benzinga
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
April 17, 2023
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
April 17, 2023
Via
Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.
Via
Benzinga
Why Shares of Prometheus Biosciences Are Soaring Monday
April 17, 2023
Merck's $10.8 billion buyout offer sent the clinical-stage biotech stock higher.
Via
The Motley Fool
Gold Drops Below $2,000; Charles Schwab Earnings Top Views
April 17, 2023
U.S. stocks traded mostly flat midway through trading, following the release of economic data. The Dow traded up 0.01% to 33,890.03 while the NASDAQ fell 0.18% to 12,101.34. The S&P 500, also fell,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
April 17, 2023
Via
Benzinga
US Stocks Mostly Flat; NY Empire State Manufacturing Index Surges In April
April 17, 2023
U.S. stocks traded mostly flat this morning, following the release of economic data. Following the market opening Monday, the Dow traded up 0.04% to 33,901.46 while the NASDAQ fell 0.09% to 12,112.19....
Via
Benzinga
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
April 17, 2023
Merck is branching into immune-mediated diseases with this takeover.
Via
Investor's Business Daily
PRST Stock Alert: What to Know About Red-Hot Presto Automation Today
April 17, 2023
Presto Automation (PRST) stock is seeing massive gains with heavy trading on Monday despite a lack of news from the AI company.
Via
InvestorPlace
Why Is NIO Stock Up Today?
April 17, 2023
Nio (NIO) stock is climbing higher on Monday after the EV company announced the launch of its new power charging stations.
Via
InvestorPlace
RXDX Stock Alert: The $10.8 Billion Reason Prometheus Biosciences Is Surging Today
April 17, 2023
RXDX stock is soaring today as Merck is officially acquiring Prometheus Biosciences. Here's what investors should know today.
Via
InvestorPlace
Why Is SAI.TECH Global (SAI) Stock Down 32% Today?
April 17, 2023
SAI.TECH Global (SAI) stock is down on Monday despite a lack of news concerning the Bitcoin (BTC-USD) mining and clean energy company.
Via
InvestorPlace
Why Is Marpai (MRAI) Stock Down 40% Today?
April 17, 2023
Marpai (MRAI) stock is taking a beating on Monday after the company announced a proposed public offering for its shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 17, 2023
Via
Benzinga
XPeng Is Charging Higher, but This Biotech Stock Is Monday's Biggest Winner
April 17, 2023
Markets are watching corporate earnings very carefully.
Via
The Motley Fool
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
April 17, 2023
Prometheus Biosciences (RXDX) stock is on the rise Monday after the company revealed a $10.8 billion acquisition deal with Merck (MRK).
Via
InvestorPlace
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
April 17, 2023
Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday.
Via
Benzinga
Merck Acquires Prometheus Biosciences For $10.8B, Strengthening Its Immunology Pipeline
April 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 17, 2023
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
Nasdaq, S&P 500 Futures Muted; Analyst Says Don't Expect Good News This Earnings Season
April 17, 2023
Early indications suggest that stocks could start the week on a tentative note, which was characteristic of trading during most of last week. Traders may show restraint as they look ahead to...
Via
Benzinga
Prometheus Biosciences, XPeng And Other Big Stocks Moving Higher In Monday's Pre-Market Session
April 17, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 70.1% to $193.93...
Via
Benzinga
RXDX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Prometheus Biosciences, Inc. is Fair to Shareholders
April 16, 2023
From
Halper Sadeh LLC
Via
Business Wire
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
April 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
April 16, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Prometheus Biosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 09, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.